Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, two-phase study to assess the efficacy of single
pulsed-dose flutamide in creating double strand breaks (DSBs) in prostate cancer within
patients receiving central androgen suppression and brachytherapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins